Effect of Drying Before Plastic Wrapping on Thermal Losses in Very Preterm Infants at Birth (NEODRY)

February 21, 2023 updated by: Daniele Trevisanuto, University Hospital Padova

Effect of Drying Before Plastic Wrapping on Thermal Losses in Very Preterm Infants at Birth: a Multicenter, Randomized Controlled Trial

This is a multicenter, unblinded, randomized controlled trial comparing drying vs. not drying before plastic wrapping for the thermoregulation of very preterm infants at birth. The aim of this study will be to compare two modes of thermal management (plastic wrapping with or without drying) for preventing heat loss at birth in very preterm infants.

Study Overview

Detailed Description

Background: Hypothermia in preterm infants during the immediate postnatal phase is associated with morbidity and mortality and remains an unresolved, worldwide challenge.

A list of interventions, including adequate room temperature, use of infant warmers, polyethylene bags/wrap, pre-heated mattresses, caps and heated and humidified gases, to prevent thermal loss at birth in very preterm infants has been recommended, but a certain percentage of very preterm infants are hypothermic at the time of the neonatal intensive care unit (NICU) admission suggesting that further measures are needed. While drying is recommended for the thermal management of infants with gestational age >32 weeks, this procedure is not indicated for very preterm infants who should be put in a plastic wrap immediately at birth without drying. However, such indication is based on studies comparing wrapping without drying vs. drying without wrapping, while the potential advantages of combining these interventions were not explored. We hypothesized that drying before wrapping could prevent heat loss immediately after birth and reduce hypothermia at NICU admission in very preterm infants.

Objective: The aim of this study will be to compare two modes of thermal management (plastic wrapping with or without drying) for preventing heat loss at birth in very preterm infants.

Methods: This is a multicenter, unblinded, randomized controlled trial comparing drying vs. not drying before plastic wrapping for the thermoregulation of very preterm infants at birth. After obtaining parental consent, all infants with estimated birth weight <1500 g and/or gestational age ≤30+6 weeks will be assigned to be managed with or without drying before plastic wrapping. Room temperature and maternal temperature will be measured at the time of delivery. Patients allocated in both groups will be managed based on the current guidelines for neonatal resuscitation. The primary outcome measure will be the proportion of neonates in the normal thermal range (temperature 36.5-37.5°C) at NICU admission. Secondary outcome measures will be: proportion of neonates with hypothermia (<36.5°C and <36.0°C) at NICU admission; proportion of hyperthermic neonates (temperature >37.5°C) at NICU admission; temperature at 1 hour after NICU admission; proportion of intraventricular hemorrhage; proportion of respiratory distress syndrome; proportion of late onset sepsis; proportion of bronchopulmonary dysplasia; mortality before hospital discharge.

Study Type

Interventional

Enrollment (Anticipated)

346

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Padova, Italy, 35128
        • Azienda Ospedaliera di Padova, University of Padova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 6 months (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Estimated birth weight <1500 g and/or gestational age ≤30+6 weeks (and)
  • Inborn (and)
  • Parental consent; written informed consent will be obtained by a member of the neonatal team involved in the study from a parent or guardian at the maternal admission to the Obstetric Department.

Exclusion Criteria:

  • Major congenital malformations (i.e. cardiac disease, defects of abdominal wall, ...);
  • Outborn;
  • Parental refusal to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Drying before wrapping
Immediately after birth, the infant's body will be dried before wrapping in a plastic bag
Immediately after birth, the infant's body will be dried before wrapping in a plastic bag
Active Comparator: No drying before wrapping
Immediately after birth, the infant will be wrapped in a plastic bag without drying
Immediately after birth, the infant will be put in a plastic bag without wrapping

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number (percentage) of neonates in the normal thermal range (temperature 36.5-37.5°C) at Neonatal Intensive Care Unit admission.
Time Frame: 25 minutes
25 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number (percentage) of neonates with hypothermia (temperature <36.5°C) at neonatal intensive care unit admission
Time Frame: 25 minutes
25 minutes
Number (percentage) of neonates with moderate-severe hypothermia (temperature <36.0°C) at neonatal intensive care unit admission
Time Frame: 25 minutes
25 minutes
Number (percentage) of neonates hyperthermia (temperature >37.5°C) at NICU admission at neonatal intensive care unit admission
Time Frame: 25 minutes
25 minutes
Temperature at 1 hour after neonatal intensive care unit admission
Time Frame: 60 minutes
Axillary temperature will be registered at 1 hour after neonatal intensive care unit admission
60 minutes
Number (percentage) of infants with intraventricular hemorrhage (all grades and grade III-IV)
Time Frame: 10 days
The grade of intraventricular hemorrhage will be defined on Levine classification
10 days
Number (percentage) of infants with respiratory distress syndrome
Time Frame: 72 hours
Respiratory distress syndrome will be defined as presence of clinical signs of respiratory distress and radiological findings
72 hours
Number (percentage) of infants with late-onset sepsis
Time Frame: 7 days
Sespsis will be defined based on the presence of a positive blood colture 72 hours after birth
7 days
Number (percentage) of infants with bronchopulmonary dysplasia
Time Frame: 36 postnatal weeks
Bronchopulmonary dysplasia will be defined as the need for oxygen at 36 postnatal weeks gestation
36 postnatal weeks
Number (percentage) of infants died before hospital discharge
Time Frame: 5 months
5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2023

Primary Completion (Anticipated)

October 31, 2023

Study Completion (Anticipated)

October 31, 2023

Study Registration Dates

First Submitted

February 7, 2023

First Submitted That Met QC Criteria

February 21, 2023

First Posted (Estimate)

February 22, 2023

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 21, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • NEOUNIPD2(2023)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be shared with other researchers upon motivated request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temperature Regulation; Disorder, Fetus or Newborn

Clinical Trials on Drying before wrapping

Subscribe